Hims & Hers (HIMS) Director Christopher Payne Receives RSU Award (545)

What Happened

• Christopher D. Payne, a director of Hims & Hers Health, Inc. (HIMS), was granted 545 restricted stock units (RSUs) on 2026-08-14 under the company's director compensation policy. The grant value was $16,598 based on a grant price of $30.40 per share.
• The Form 4 shows derivative transaction code M (exercise/conversion): 545 shares were reported as acquired and 545 shares reported as disposed at $0.00. This filing corresponds to the issuance of RSUs (a contingent right to receive one share per RSU), not a market purchase or sale.

Key Details

• Transaction date: 2026-08-14; Form 4 filed: 2026-08-18 (timely).
• Amount: 545 RSUs; grant price used for calculation: $30.40; total value reported: $16,598.
• Reported transactions: 545 shares acquired (conversion/exercise, code M) and 545 shares disposed at $0.00 (not a cash sale).
• Shares owned after the transaction: not disclosed in the provided excerpt.
• Footnote: RSUs were issued in lieu of the director cash retainer for Q2 2026; the RSUs will vest in full on the company's next quarterly vesting date.

Context

• RSUs are awards that convert into shares only upon vesting; they are routine director compensation and do not necessarily indicate a buying or selling signal. The reported disposal at $0.00 means no cash sale occurred on the open market as part of this filing.
• Transaction code M denotes conversion/exercise of a derivative; here it reflects the RSU award mechanics rather than an option exercise followed by a market sale.